November 5–6, 2019
Join Genedata experts at the 13th Drug Discovery conference. Ask for a demonstration of Genedata Screener® or Genedata Imagence® at booth #G1.
Don't miss the opportunity to see how Genedata Screener analyzes, visualizes, and manages screening data from in-vitro screening assay technologies across the enterprise, including very complex as well as ultra-high throughput experiments. Its screening-oriented business logic enables rapid processing and comprehensive analysis of complete campaigns.
If you would like to schedule a meeting in advance or receive more information on Genedata Screener, please contact firstname.lastname@example.org.
You also have the chance to find out more about our new solution, Genedata Imagence, a high content screening (HCS) image analysis software based on deep learning. To get more information about Imagence or to arrange a meeting, please contact email@example.com.
Genedata Imagence® - Deep Learning Automates the Analysis of Cell Painting Assays
Cameron Scott, PhD, Scientific Account Manager, Genedata
Big Data & Artificial Intelligence
Tuesday, November 5 | 12:20–12:25
Here we show how the new software solution Genedata Imagence enabled the complete analysis of a Cell Painting screen of 1’500 test compounds within a few hours. In our case study we employed this workflow to train a neural network to recognize the cell-painted phenotypes of reference compounds with known mode-of-action (MoA). This network was used to analyze the entire BBBC022 data set and successfully detected compounds with similar MoA.
Genedata Imagence provides a streamlined workflow that facilitates discovery by making powerful deep learning approaches intuitive and easily accessible to any HCS biologist.
A Highly Automated End-to-End Analysis Workflow for High-Throughput Mass Spectrometry Screening
Steigele S., Bobby R., Sinclair I., Yee A.X., Wingfield J., Heyse S.